MRM Health raised €55M in a Series B round in Sep 2025. The company is based in Ghent, Belgium. Investors in the round: Ackermans & van Haaren (AvH), ATHOS CAPITAL, Biocodex and 5 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €55M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.